Jennifer Wong-Roushar
Biochemistry, Genetics and Molecular Biology · Indiana University
Publications
140
Citations
1,420
Est. group size
—
Recurring co-author estimate
Active years
46
Publishing since 1981
Jennifer Wong-Roushar's research centers on cancer biochemistry and metabolism, with a recent focus on how ovarian cancer cells that resist the chemotherapy drug cisplatin depend on one-carbon metabolism (a set of cellular chemical pathways involving folate and related molecules). This work explores targeting these metabolic pathways as a potential treatment strategy against drug-resistant tumors.
Publication activity has grown considerably in recent years, peaking around 2023–2024, though much of the recent output consists of supplemental data files tied to a single study.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Supplemental Table S3 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer
2026
- Supplemental Table S2 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer
2026
- Supplemental Figure S6 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer
2026
- Supplemental Figure S2 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer
2026
- Supplemental Table S4 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer
2026
- Supplemental Figure S3 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer
2026
- Supplemental Figure S5 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer
2026
- Supplemental Table S5 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer
2026
- Supplemental Table S6 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer
2026
- Supplemental Figure S4 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer
2026
- Supplemental Figure S1 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer
2026
- Supplemental Table S1 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer
2026
- Challenges in the treatment of persistent air leak
Current Challenges in Thoracic Surgery · 2025
- Learning to Traverse the Surface and Deep Structure in Music Analysis, via Inquiry and Reflexing on Theory
2025
- Supplemental Table S2 from Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer
2024
- Molecular Cancer Therapeutics×3
- Cancer Research×3
- Infection and Immunity×1
- BMC Biotechnology×1
- Clinical Physiology and Functional Imaging×1
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile